HHC
At Eisai, we give first thought to patients and their families, and to increasing the benefits that health care provides. We call this human health care (hhc).

Welcome

Welcome to the Eisai UK website. Eisai (pronounced 'ā-zī’) is derived from the Japanese word for 'health product' and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. Working across the spectrum of pharmaceuticals and consumer health, chemicals and food additives, production systems and equipment, we are a human healthcare company that actively participates with, and contributes to, any healthcare system. We place primary emphasis on patients and their families, and observe the highest legal and ethical standards in our business activities.

Eisai opens European Knowledge Centre (EKC)

The EKC represents one of Eisai’s biggest ever single capital projects and fulfils the company's long held ambition to bring teams from across its business together on one site for the first time. The aim is to stimulate knowledge creation between teams – from those who create products through research and clinical trials, to those who produce, market and sell them - by bringing them together on one site with all the necessary support functions. read more»

 

What’s Inside

Understand more about Eisai's corporate history and philosophy in About Us, where you can also find financial highlights. Learn about our current Products and see how a unique Drug Development approach will ensure a more productive future programme and a healthy flow of new medicines in development. Discover what it's like to work at Eisai and visit our regularly updated list of job vacancies in the Careers section, where you can apply for a specific posting, or simply submit your CV for consideration. Find out what's new in our Home page feature, and keep up-to-date with the latest news on our global website via the News section. Communicating with Eisai, or finding out how to get here, is easy via Contact Us.

Understanding the future information for investors